David Kerr
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Genetics top 1%
- Diabetes and associated disorders
Papers in
-
- Diabetes Management and Research 110
- Diabetes Treatment and Management 28
- Diabetes Management and Education 25
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 24
-
- Mobile Health and mHealth Applications 31
- Co-authors
- Peter ThomasJanet JamesDavid CavanTristan RichardsonDavid C. KlonoffIan MacdonaldSimon HellerMoshe Phillip
- Journals
- Journal of Diabetes Science and Technology (38 papers)Diabetic Medicine (22 papers)Diabetes Care (16 papers)Diabetes Technology & Therapeutics (8 papers)Diabetes (5 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
David Kerr
212 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- Endocrinology, Diabetes and Metabolism 3.6k
- Genetics 1.4k
- Pharmacy 185
- Surgery 1.6k
- Public Health, Environmental and Occupational Health 1.1k
Countries citing papers authored by David Kerr
This map shows the geographic impact of David Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kerr more than expected).
Fields of papers citing papers by David Kerr
This network shows the impact of papers produced by David Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kerr. The network helps show where David Kerr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Kerr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 21 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 16 | |
| 12 | 2021 | 20 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 190 | |
| 15 | 2019 | 10 | |
| 16 | 2019 | 21 | |
| 17 | 2018 | 101 | |
| 18 | 2013 | 2 | |
| 19 | 2007 | 17 | |
| 20 | Automatic screening for diabetic retinopathy using digital image analysis and statistical classification | 1997 | 3 |
About David Kerr
David Kerr is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions, Family Practice, Genetics and Applied Psychology, having authored 221 papers that have together received 6.8k indexed citations. Recurring topics across this work include Diabetes Management and Research (110 papers), Diabetes and associated disorders (37 papers), Mobile Health and mHealth Applications (31 papers), Pancreatic function and diabetes (31 papers), Diabetes Treatment and Management (28 papers), Diabetes Management and Education (25 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (24 papers) and Diet and metabolism studies (16 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.6k citations), Genetics (1.4k citations), Pharmacy (185 citations), Surgery (1.6k citations) and Public Health, Environmental and Occupational Health (1.1k citations). David Kerr has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Peter Thomas, Janet James, David Cavan, Tristan Richardson, David C. Klonoff, Ian Macdonald, Simon Heller, Moshe Phillip, Jan Bolinder and Jean-Pierre Riveline. Their work appears in journals such as Journal of Diabetes Science and Technology, Diabetic Medicine, Diabetes Care, Diabetes Technology & Therapeutics and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.